4//SEC Filing
Deardorf Caren 4
Accession 0000899243-22-021185
CIK 0001690585other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:05 PM ET
Size
5.2 KB
Accession
0000899243-22-021185
Insider Transaction Report
Form 4
Deardorf Caren
Chief Commercial Officer
Transactions
- Award
Common Stock
2022-05-31$0.99/sh+3,000$2,970→ 16,762 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Magenta Therapeutics, Inc. 2019 Employee Stock Purchase Plan (the "ESPP") for the ESPP purchase period of December 1, 2021 through May 31, 2022. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d).
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on May 31, 2022.
Documents
Issuer
Magenta Therapeutics, Inc.
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001871152
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 4:05 PM ET
- Size
- 5.2 KB